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INTRODUCTION 
Microbiota 
Microbiota or microbial flora is “the microscopic living organisms of a region” 
(1). It locates in the human gastrointestinal tract and has an effect on our health and 
well-being.  Microbiota has significant influence role in host metabolism and also 
helps supplies a natural defense mechanism barrier against invading pathogens. 
Different bacterial groups are found throughout the gastrointestinal tract from mouth 
to colon in various amounts.  
In the human digestive tract, the population of microflora is a very complex but 
rather stable ecological community (2).  The human GI tract is populated by an 
excess of 1010 bacterial cells per gram, at least 1012 living bacterial cells in the entire 
colon (3), that make up from at least 500 different bacterial species (4). In the large 
intestine, bacteria such as Bacteroides, Bifidobacterium, Eubacterium, Clostridium, 
Fusobacterium and Ruminococcus are usually found.  Inflammatory bowel disease 
or the use of antibiotics can affect the defense mechanisms provided by the 
intestine’s bacterial community. For this reason many foods are scientifically 
intended to help strengthen the gut’s defense system.  These ‘functional foods’ work 
by adding probiotic organisms and claim to have a health benefit above basic 
nutritional value. Functional Foods were first developed in 1980s in Japan (5).  
 
Aging 
The composition of the gastrointestinal (GI) microflora changes with the 
increased age of the host (6).  This is mainly due to alterations in dietary habits and 
in GI physiology. Aging, for instance, is associated with decreased consumption of 
fiber, since fiber-rich foods tend to require more mastication than other foods (7, 8). 
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In addition, diet composition could be altered due to the decline in olfactory and 
gustatory sensitivity (9), and the decrease in cognition (10) which is sometimes 
brought on by aging. Moreover, the aging GI tract commonly undergoes 
pathophysiological processes leading to conditions such as gastric hypochlorhydria, 
intestinal dysmotility, and decreased colonic transit time (11). These conditions may 
promote the preferential growth of specific bacterial colonies, thereby altering the 
composition of the GI microbiota, which in turn affects intestinal homeostasis and 
function (12). Additionally, the pathophysiological changes seem to effect the 
regulation of essential groups of the gastrointestinal bacterial flora (13). An animal 
feeding study showed that the population of guts bacteria depends largely on age of 
animal, even with adding synbiotics into the diet (13).  One important consequence 
of the changes associated with aging is the decrease in the number and diversity of 
beneficial microbiota in elderly humans (14) and in older animals (15).  
 
 
Beneficial-Probiotic 
According to the FAO/WHO, probiotics are live microorganisms that are 
similar to beneficial microorganisms found in the human gut, when given in adequate 
amounts grant a health benefit on the host. This word came from pro ("for") in Latin 
and βιωτικός (biotic) in Greek, the latter deriving from the noun βίος (bios, "life") (16). 
Probiotics are found in fermented dairy products such as yogurt and kefir. It also is in 
granola bars, soy products and dietary supplements. Lactic acid bacteria (LAB) and 
Bifidobacterium are the most common types of microbes used as probiotics. 
Probiotics aid in preventing and treating a wide variety of diseases, from acute 
gastroenteritis to intestinal neoplasia (17). According to the American 
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Gastroenterological Association, research shows that probiotics help boost immune 
system, prevent infection, strengthen the barrier of the intestine and inhibit or destroy 
toxins. The studies also show that probiotics also relieve the symptoms of irritable 
bowel syndrome symptoms like constipation, diarrhea, abdominal cramps and other 
disorders.  
To grant a significant health benefit, the ideal probiotic should be resistant to 
gastric acid digestion, to bile salts, and remain viable in the intestine in order to have 
greater immunologic effects and should be able to adhere to the intestinal epithelium 
wall (18, 19). 
Some microbiotas are derived from the human intestine while others are 
nonhuman strains used in the fermentation of dairy products. Most probiotics are 
strains of Bifidobacterium or the Lactobacillus species. Some other bacteria like 
Streptococcus, Bacillus, and Enterococcus were also used but there are less prefer 
since the might contain some pathogen like Enterococcus (20). Yeasts such as 
Saccharomyces genus are also known for probiotics properties.  
Research shows that probiotics have also managed the symptoms of 
diarrheal diseases. Statistically, the prevention of antibiotic-associated diarrhea 
could be done by supply the mixture of yeast Saccharomyces boulardii and the 
bacterium Lactobacillus acidophilus combined with L. bulgaricus, L. rhamnosus 
strain GG [American Type Culture Collection (ATCC) 53103; LGG], and 
Enterococcus faecium strain SF68.  These help to reduce the length of diarrhea by 
>30 h (21). 
Another research study has shown the effect of a probiotic mix (containing 3 × 
1011 CFU L. bulgaricus, L. casei, L. plantarum, L. acidophilus, Bifidobacterium 
longum, B. breve, B. infantis, and S. thermophilus) preventing flares of chronic 
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pouchitis in patients with inflammatory bowel disease (22) and that by using of a 
different probiotic mix [B. lactis Bb12 and Lactobacillus reuteri (ATCC 55730) at 1 × 
107 CFU/g in a cow milk formula] could prohibit diarrheal in infants attending 
childcare (23).  
Even though probiotic mostly have the major clinical effects on 
gastrointestinal disorder, but some were shown to effect non-gastrointestinal 
diseases such as the treatment and prevention of atopic eczema (24).  
Lactobacilli and Bifidobacterium represent two important groups of probiotic 
bacteria in intestinal micro flora. They have unique properties which provide the 
benefits to the host body in several ways. 
 
Bifidobacterium 
Bifidobacterium is gram-positive, anaerobic, nonmotile, nonsporeforming rods 
of variable appearance somewhat irregular or branched rod shaped bacteria. 
Bifidobacterium has a hexose metabolism through a phosphoketolase pathway or 
bifid shunt, and uses the key enzyme frutose-6-phosphate phosphoketolase 
(F6PPK). It is generally used as a diagnostic test for this Bifidobacterium as it is not 
found in other gram-positive intestinal bacteria. Bifidobacterium is to “commensal 
relationship” in human–microbe interactions. In newborn infants, colonization inside 
gastrointestinal tract begins the moment after birth (25). Mode of delivery, initial diet, 
geographical location and type of delivery dictate the colonization pattern (26). 
Generally, Bifidobacterium infantis, B. brevi, and B. longum are the largest group of 
bacteria in the intestine of infants. The number of Bifidobacterium remains relatively 
stable representing 3–6% of the fecal flora and started to decline in advanced age 
(27).  Bifidobacterium occupy a large percentage compared to other microflora in the 
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gastrointestinal region, said to be the 3rd or 4th largest group in adults because they 
can use many source of molecule for energy (28). For example, B. longum genome 
codes for variety of enzymes that use for catabolism of oligosaccharides, 
nondigestible fiber, host-derived glycoproteins and glycoconjugates (29). 
The different species of Bifidobacterium have seen a great increase in 
commercial and consequent scientific interest in lately, due to the ability to relive 
many types of disorders. 
 Antibiotics have an effect on the intestinal microflora community by 
decreasing the ability to colonize and promoting the growth of putrefactive microbes 
like Clostridium and Klebsiella species. Bifidobacterium, such as B. longum, has 
shown to reduce the incidence and duration of antibiotic-associated diarrhea (30, 
31). 
Research shows that the traveler’s diarrhea incident can be reduce by using 
the combination of Bifidobacterium and other probiotic strains from 71 to 43% in 
tourists travelling to Egypt by given capsules of S. thermophilus, Lactobacillus 
bulgarius, Lactobacillus acidophilus and B. bifidum (32). 
Research also shows that Bifidobacterium has anti-inflammatory capacity in 
vitro by inhibiting LPS-induced NF-κB activation (33). Further research also shows 
that Bifidobacterium has therapeutic effects in allergy and inflammatory disorders by 
activating MAPK, GSK3 and PI3K in order to modulate DC biological functions (34). 
For individual who suffer lactose intolerance, Bifidobacterium longum was 
shown to have a potential probiotic treatment effect on the relieving of the symptoms 
(35). 
The population of Bifidobacterium is high in infants and starts decline with 
age. Hence, infants intestinal microflora have the antagonistic activities and ability to 
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resist certain enteric infections and work more effectively compared to adults with a 
lower count of indigenous Bifidobacterium using the mechanism such as the 
production of various acids, hydrogen peroxide or bacteriocins, the competition for 
nutrients or adhesion receptors, anti-toxin action and stimulation of the immune 
system (36). With age, Bifidobacterium population is inversely proportional to the 
number of Clostridium perfringens detected in the elderly (37). 
After lung cancer in men and breast cancer in women, colorectal cancer is the 
second most common cancer in Europe via epidemiological study data.  Indirect 
result of some studies show that probiotic microflora help prevent, or delay the onset 
of certain cancers. The reason is the increasing levels of putrefactive microbes and a 
decrease in the levels of Bifidobacterium that cause by a diet high in meat and fat 
but low in fiber (38). The fecal enzymes such as beta-glucuronidase, azoreductase, 
urease and nitroreductase convert procarcinogens into carcinogens and may be a 
factor on an increased risk for colorectal cancer (39). Bifidobacterium‘s conjugated 
linoleic acid production is also believed to yield anticarcinogenic effects (40). 
Bifidobacterium longum and B. breve are believed to help prevent DNA damage by 
carcinogens (41). Bifidobacterium longum has also been recognized as aiding the 
reduction of aberrant crypt foci (ACF) occurrence in rats (42), which induce the anti-
tumor activity. 
A mixture of four Lactobacillus strains, three Bifidobacterium species (B. 
breve, B. infantis, B. longum) and a Streptococcus thermophilus strain have shown 
to have an effect on therapeutic and prophylaxis of inflammatory bowel syndrome 
(IBD) (43). IBD, a disruption in bowel habits and mucosal inflammation, is the 
overlapping phenotypes of Crohn’s disease and ulcerative colitis. The causes are 
still unclear but could be due to the genetic disposition and intestinal microflora. 
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There is evidence to suggest that the IBD symptom could be alleviated by the 
modification of the composition of microflora (44).The mechanism, still under 
investigation, could be the mucosa‘s cytokine transcription factors and regulation 
response to invasive microbes as well as interaction with mucosal regulatory T cells 
(45). 
Another health benefit related to Bifidobacterium is the prevention and relief of 
constipation, especially in elderly. Probiotics have also been used to enhance the 
growth of Bifidobacterium in large intestine and have been found to have laxative 
effect (46). In another study, B. bifidum was shown to have the ability to relieve 
severe premenstrual syndrome (PMS) in relation to the gastrointestinal symptoms 
such as constipation, diarrhea and abdominal pain (47). 
Since another duty of GI tract, beside absorption and digestion, are the 
defense barrier against antigens from microorganism and food, and then we can 
assume that probiotic is directly impacting the host’s immunity function. For example, 
B. lactis can induce the natural immune function by dietary consumption (48) and B. 
bifidum also shows the possibility to increase the immunomodulation effect in 
combination with other probiotic strains when consumed in cheese (49). B. infantis 
show an immunoregulatory role in the repression of Th2 cytokines during antigen 
sensitization (50). 
Lastly, probiotic Bifidobacterium shows some evidence that it might assist on 
reducing the serum cholesterol that would lead to lower chances of cardiovascular 
disease (51). Probiotic intake increases the production of the enzyme bile salt 
hydrolase which shows decrease the serum cholesterol levels (52). 
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Lactobacillus 
Lactobacillus is a gram-positive facultative anaerobic (microaerophilic), rod-
shaped bacteria. They are the primary of the lactic acid bacteria group, which 
converts lactose and other sugars to lactic acid. In humans, they are present as a 
small group of gut flora and also found in vagina (53). Lactobacillus produces lactic 
acid, which also lowers the pH of the fermenting substance that is used in food 
productions such as yogurt, cheese, pickled, and starter culture for sourdough. In 
beer production, L. casei and L. brevis are commonly used as a beer spoilage 
organism. 
According to the Beth Israel Deaconess Medical Center and UCLA in 2009, 
They believed that some strains of Lactobacillus spp. and other lactic acid bacteria 
can help prevent tumor and cancer  especially a colonic tumors (54). 
A mixture of Lactobacillus species, Enterococcus species, and S. boulardii 
were shown to improve the infective diarrhea in both adults and children (55). 
Other benefits by oral administration are shown to decreased the chance of 
DNA adducts formation, ameliorated DNA damage and prevented putative 
preneoplastic lesions  such as aberrant crypt foci in the gastrointestinal tract (56). 
Lactobacilli is believed to help improve the gut micro flora and combat against 
unwanted bacteria with regular consumption, for example the production of natural 
agent “bulgarican” from L. acidophilus and L. bulgaricus .Bulgarican help fight 
against the spreading of other unwanted bacteria species in foods and in the human 
gut. Active Lactobacilli micro-flora has ability to alter the pH by producing lactic acid 
in large intestine, as a result, these created the uninhabitable environment for 
spoilage bacteria. It also helps destroyed other undesirable microbe like moulds, 
mould spores and yeast, especially Candida form. Lactobacilli can also be used to 
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restore physiological balance of the vaginal and helps protect the ecosystem from 
other bacterial infection (56). 
Other benefits of Lactobacillus is the production of enzymes which when 
exposed to food, help break down the structure of that substance so the nutrients are 
easy to absorb by human digestive system and often increase  the biological value of 
foods. The enzyme activity also benefits greatly in aged population where digestive 
efficiency tends to weaken when age progress (56). 
 
Gram positive bacteria cell wall  
The gram-positive cell wall consists of tough mesh, several rows and layer of 
peptidoglycan and teichoic acid, cross linked with lipoteichoic acid molecule and 
surface proteins. These structures provide strength and rigidity while maintaining 
elasticity and flexibility to offset intracellular turgor pressure associated with the 
maintaining of cell shape and preventing against osmotic lysis. 
Peptidoglycan, made 60-90% of the cell wall structure and thicker in gram 
positive bacteria, is made of rigid glycan chains of N-acetylglucosamine (GlcNAc) 
and N-acetylemuramic acid (MurNAc), connected by b-1, 4 glycosidic bonds and 
cross linked by flexible peptide bridge making a glycan numerous interconnecting 
layer 20-80 nm thick (57). 
Teichoic acid, which is a unique gram positive bacteria cell wall, is a polyribitol 
phosphate and glycerol phosphate, cross linked to peptide glycan making the outer 
layer. Teichoic acid attaches the cations, like magnesium and sodium, in order to 
maintain the stability and rigidity for the bacteria cell wall.  
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Lipoteichoic acid, cytoplasmic membrane lipids, works as a lipid link to the 
teichoic acid. These substances are combined to form the covalent multilayered 
structure. 
Even though peptidoglycan presents in both gram positive and gram negative 
bacteria cell wall, gram positive cell wall contain more in quantity, chain length, the 
degree of cross link and the thickness (58). The lyses of a strong peptidoglycan 
barrier pose a challenge to overcome in order to disrupt the cell wall (59). 
Other characteristics of the gram positive bacteria cell wall that interfere with 
the lysis process are; The petidoglycan layer are thick and abundant, and also 
contain many cross-linked 50 nm wind glycan strands that provided even more 
strength. Second, the covalent bond of the teichoic acid to the lipoteichoic acids 
causes interwoven in the cell wall. Third, each strain and species of the bacterium 
are different depending on the type of surface protein on the outer layer of 
peptidoglycan. Lastly, the viscous material that is presents in the periplasm region 
between the peptidoglycan layer and cytoplasmic membrane helps provide another 
barrier for the cell (60). 
Microbiota development and characterization in the human host still rests 
largely on culture-dependent methods (11). These conventional methods have 
many drawbacks. First, their sensitivity is rather low. Second, they are quite time 
consuming and therefore not very cost-effective. Third, a cultural method requires 
the use of a fresh sample and to perform operations after sampling. Some might be 
limited to a difficult condition, like anaerobic culturing, while PCR is not. Next, PCR 
sample can be preserved in the freezer and transported in the distant future. Forth 
and most importantly, since only certain bacterial species and strains are amenable 
to culture, the results could be biased (certain bacterial populations might be 
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overestimated, while others might be missed). Thus, during the last decade, 
developments in molecular biology have led to the application of fast and reliable 
alternative culture-independent methods (61).  For instance, in one study by De 
Vrese et al., quantitative real time PCR was utilized to estimate the levels of certain 
bacterial populations in the intestines of mice (62). 
The aim of this study was to establish a method to detect the gastrointestinal 
tract microbiota, either by fecal or colonic tissue DNA extraction. 
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Figure1: Adhesins in the bacterial cell wall bind to receptor molecules on the surface 
of a susceptible host cell.  
Copyright © Gary E. Kaiser All Rights Reserved Updated: January 30, 2001 
 
 
Figure2: The Gram-positive cell wall appears as dense layer typically composed of 
numerous rows of peptidoglycan, and molecules of lipoteichoic acid, wall teichoic 
acid and surface proteins.  
Copyright © Gary E. Kaiser, The community College of Baltimore County, Catonsville Campus: 
January 27, 2001 
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MATERIALS AND METHODS 
Mice 
C57BL/6, specific pathogen-free male and female mice were used. The caring 
of the animals was in accordance with the NIH guidelines for the use and care of 
laboratory animals, and the animal protocol was approved by the Institutional Animal 
Care and Use Committee of the Wayne State University Animal Investigation 
Committee. Animals were housed, two mice per cage and kept in a 12-hour dark-
light cycle, controlled environmental temperature of 22 + 2oC. Animals had free 
access to distilled water at all times. The amount of food provided was ad libitum. 
Food consumption and physical activity change were monitored daily. 
 
Fecal sample collection 
Fresh fecal samples were obtained from mice between the ages of 3 months 
to 1 year old. For collection, the mice were transferred to a cage that contains a one-
centimeter-wired-mesh grating floor for one hour. To prevent the integration of feces 
and urine, the paper towel was used as a lining on the bottom of the cage for 
absorption. The mesh allows for collection of fresh feces to avoid mixing with older 
feces from cages and to avoid contamination from bedding material. Moreover, this 
can also prevent the autocoprophagy. The feces were then collected and stored at -
20oC until further analysis. 
            
Colonic tissue sample collection 
Mice were euthanized via cervical dislocation method. They were then 
aseptically dissected and colon tissue was removed. The feces inside the intestine 
were collected for DNA extraction. The colon was rinsed and washed from the inside 
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out of the intestine using forceps and syringe (20G) with PBS solution (Fisher 
Scientific Inc. Fairlawn, New Jersey). 
The colon was collected using several different methods to assess the optimal 
and the best form of tissue collection for bacteria quantization. First, we transferred 
the colon tissue directly to a 15 ml tube containing 2 ml of DNAzol direct solution, 
manually homogenized then incubated at 95oC for 15minute, homogenized, vertex 
and spun down. 
Second, we rinsed the intestine with PBS buffer and the tissue was 
transferred onto a microscope slide on ice. The intestine was cut open by using two 
forceps holding one end of the intestine with angled serrated forceps and squeezing 
out the epithelial cells with the other forceps by running the smooth-edged forceps 
slowly to the other end of the tube. The epithelia cells were suspended in 1 ml of 
DNAzol direct solution. The rest of colon muscularis was also transferred into 2 ml of 
DNAzol direct solution. We then continued with the rest of the extraction protocol 
using the same process as the first condition. 
 
Strain culture 
In order to generate a positive control for Bifidobacterium experiments, we 
purchased DNA of B. adolescentis cat#15703D, B. breve cat#15700D-5 and B. 
infantis from ATCC (Manassas, VA). In addition, we grew a culture of 
Bifidobacterium breve; ATCC#15701- freeze-dried culture, which also was obtained 
from ATCC. Aseptically rehydration and inoculation of the culture was made using 
Difcoreinforced Clostridial medium (Becton, Dickinson and Company. Franklin 
Lakes, NJ). Inoculum broth was incubated at 37°C for 24 hours under anaerobic 
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conditions generated using the GasPak EZ anaerobe container system (Becton, 
Dickinson and Company. Franklin Lakes, NJ).Then the bacteria were cultured on 
agar plates using the same media and conditions. This provided a means for the 
evaluating PCR primer and DNA extraction method efficiency. 
 
DNA extraction 
DNA was extracted from feces for PCR detection. In addition DNA was 
extracted from entire colon and colonic scraping for PCR detection as well. 
ZR Fecal DNA kit (ZYMO RESEARCH CORP. Orange, CA Catalog no.D6010) 
 The protocol was adapted from the manufacturer’s instruction manual. The 
principle of this method was to lyses and centrifuged using ultra-high density beads 
that is fracture resistant and chemically inert.  
We added up to 75 mg of fecal sample to a lysis tube, and then filled with 750 
ul lysis buffer to the tube. Vertex for 10 minutes. Centrifuged the lysis tube in a micro 
centrifuge at ≥10,000 x g for 1 minute. Transferred up to 400 ul supernatant to a spin 
filter in a collection tube and centrifuged at 7,000 rpm (~7,000 xg) for 1 minute, 
added 1,200 ul of fecal DNA binding buffer to the filtrate. Then transferred 800 ul of 
the mixture to a column in a collection tube and centrifuged at 10,000 xg for 1 
minute. Discarded the flow through from the collection tube and repeated the 
centrifuge for another 1 minute. Added 200 ul DNA pre-wash buffers to the column in 
a new collection tube and centrifuged at 10,000 xg for 1 minute. After that, added 
500 ul fecal DNA wash buffer to the column and centrifuged at 10,000 xg for 1 
minute. Transferred column to a clean 1.5 ml micro centrifuge tube and added 100 ul 
(25 ul minimum) DNA Elution Buffer directly to the column matrix, centrifuged at 
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10,000 xg for 30 seconds to elude the DNA. Transferred the eluted DNA to a spin 
filter in a clean 1.5 ml micro centrifuge tube and centrifuged at exactly 8,000 xg for 1 
minute. DNA extracted was stored at -20°C until its use. 
 
DNAzol Direct (Molecular Research Center, Inc. Cincinnati, OH) 
 In addition to ZR fecal kit, we also utilized DNAzol to determine which method 
gave the best quality DNA. 
 DNAzol direct is the reagent that was used for processing biological samples 
for the direct PCR, using alkaline solution containing polyethylene glycol and other 
additive to lyse the sample and releasing the DNA into the lysate. The combined 
effects of the alkaline pH and chaotropic properties induce the inactivation of PCR 
inhibitor such as protease and nucleic acid degradation enzyme. 
To extract, we mixed up approximate 1-10 mg of fecal sample with 0.1 ml 
Nuclease-free water (Thermo Fisher Scientific Inc. Pittsburgh, PA). Hand-
homogenized until mixed well then we added 0.1 ml of DNAzol Direct. To ensure the 
maximum yield, we incubated the mixture at 95 °C using heating block for 15 
minutes. Vortexes the lysate for 30 seconds and transferred a 2 ul aliquot directly 
into the PCR mix, or froze at -20 °C until use. 
For the bacteria colony, we picked one colony then mixed directly into 0.1 ml 
of DNAzol Directed and continued to incubation as explained above. 
 
Quantitative reading of DNA/RNA 
The quantitative of DNA/RNA were measured using The Thermo Scientific 
NanoDrop (series) spectrophotometer. The spectrophotometer measurement and 
the absorbance of the total molecule in the sample of interest, each wave length 
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represent different molecule; 230 indicates the presence of organic compound 
contaminants i.e. carbohydrates, phenol and EDTA. A260 shows the total of 
nucleotides, RNA, ssDNA, and dsDNA. While A280 exhibits the concentration of 
proteins content. The ratios of each value indicate the quality of sample: 
260/280 ratio indicates the purity of DNA and RNA. A ratio of ~1.8 is generally 
accepted as “pure” for DNA while a ratio of ~2.0 is generally accepted as “pure” for 
RNA. If the ratio is lower in either case, it may indicate the presence of contaminants 
that absorb, at or near, 280 nm i.e. protein, phenol or other. 
260/230 ratio is used as a secondary measure of nucleic acid purity. The 260/230 
values for “pure” nucleic acid are often higher than the respective 260/280 values, 
commonly in the range of 2.0-2.2. If lower, then it may indicate the presence of 
contaminants, which absorb at 230 nm. 
 The procedure, according to the manufacturer’s manual, combines with the 
use of software program. Nuclease free water was used as standard blank sample, 
and for cleaning during each sample measurement. With the arm open, pipette 2 ul 
of sample directly onto pedestal. The pedestal automatically adjusted for an optimal 
path length (0.05 mm - 1 mm). When the measurement is complete, the surfaces are 
simply wiped with lint-free lab wipe and nuclease free water before measuring the 
next sample. Nucleic acid samples required purification prior to measurement. 
 
RNase treatment 
 To determine zero contamination of RNA in the DNA extraction, we performed 
RNase treatment using RNase enzyme (QIAGEN Inc. Valencia, CA). The RNase 
was mixed into DNA extraction at the ratio of RNase: DNA=1:10. This was incubated 
on heating block for 30 minutes at 37°C then another 10 minutes at 70°C to denature 
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the enzyme and stop the treatment process. The product was being purified using 
QIAquick PCR Purification kit, the protocol as describe in the cloning and 
sequencing section, and was used to get rid of the excess enzyme.  The product 
was kept on ice until further use. 
 
Primers 
After searching through multiple publications, PCR primers were chosen, as 
listed on Table 1. These primers were designed to target the 16s rRNA region of 
different members of Bifidobaterium species and Lactobacillus species. All of the 
oligonucleotides used were purchased from Invitrogen Corporation (Carlsbad, CA). 
All primers were tested for the primer concentration optimization. The higher primer 
concentration can increase the efficiency of PCR but can also lead to primer dimmer 
formation. The concentrations of each primer was adjusted by diluting with nuclease 
free water and mixed into 25 uL of total PCR reaction to reach the final concentration 
of 1.9, 1.0, 0.5, 0.1 and 0.05 uM. The 0.1uM final concentrations yielded the best 
results for amplifying of target DNA without primer dimmer formation in negative 
control or showed no evidence of secondary priming.  
The specificity of primers were tested by amplifying DNA from the target 
organism purchased from ATCC which were diluted into 1:10 dilution by nuclease 
free water and used as positive control throughout the experiment.  
 
Qualitative PCR  
PCR  
 The experiment started off with normal PCR. The mixture of the PCR 
mastermix of 10.1 ul of nuclease free water, 2 ul 10x PCR buffer 10x, 0.8 ul of 2.5 
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mM dNTP mix, 0.4 ul each of 25 uM working concentration forward and reverse 
primer and 1.25 ul of MgCl2 and 0.1 ul of Taq polymerase were mixed with 5 ul of 
DNA template then put in the thermocycler set the cycle parameter  at (i) 2 minutes 
at 95°C 1 cycle then (ii) 30 cycles of 30 seconds at 95°C, 1 minute at 60+X°C 
(depend on primer-should be 2 degree lesser that the annealing temperature) and 
1.50 minutes at 72°C. (iii) 1 cycle of extension step at 72°C for 5 minutes, the 
product was then put on hold at 4°C for 200 cycles or until use. 
  
Touchdown PCR 
Touchdown PCR was chosen since it was more suitable for varies annealing 
temperature of each primer. PCR master mix, Go Tag Green cat#M7122, was 
purchased from Promega Corporation (Madison, WI). Per reaction of PCR mixture 
contain 12.5 ul of master mix, 4.5 ul of nuclease free water, 2.5 ul of each forward 
and reverse primer at 1 uM working concentration and 2 ul of DNA template. 1 ul of 
DMSO (Thermo Fisher Scientific Inc. Pittsburgh, PA) was also added to improve the 
denaturation of CG-rich region in bacteria DNA double helix strands. 
Amplification was performed using theMastercycler gradient (Eppendorf AG. 
Hamburg, Germany) with the following condition: (i) a hot start step of 2 minutes at 
94°C and (ii) an initial step consisting of 1 minute at 94°C, 1 minute of 60-56°C with 2 
cycles for each degree Celsius and 1 minute of 72°C.Then (iii) 30 cycles of 1 minute 
at 94°C, 1 minute of 55°C and 1 minute of 72°C.Final extension (iv) of 7 minutes at 
72°C and put on hold at 4°C. 
To ensure the integrity of the DNA, amplification products from PCR were 
subjected to gel electrophoresis using 2% (W/V) agarose gel (Promaga BioSciences. 
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San Luis Obispo, CA) and were observed by Ethidium bromide staining. UV imager 
for qualitative analysis was used to read the results.  
 
Cloning and Sequencing 
The PCR products were purified using QIAquick PCR Purification kit 250 
(QIAGEN INC. Valencia, CA) following the manufacture protocol. Briefly, added 5 
volumes of PBI buffer were added to 1 volume of PCR product and mixed. The 
mixture was transferred into the column that had been inserted into the 2 ml 
collection tube, then centrifuged for 60 seconds, discarded the flow-through. To 
wash, 0.75 ml PE buffer was added into the column then centrifuge for 60 seconds, 
discarded the flow-through. Centrifuged the column for an additional 1 minute and 
moved the column to the new 1.5 micro centrifuge tube. To eluted DNA, added 30 ul 
of nuclease free water to the center of the membrane, let the column stand for 1 
minute and centrifuged for 1 minute. Increased DNA concentration by pipetted the 
flow-through and put back to the center of the membrane and centrifuged for 1 
minute. 
  Purified DNA fragment was then inserted into plasmid and transform into 1-
shot cells using TopoTA cloning kit (Invitrogen Corporation. Carlsbad, CA) according 
to the protocol. Briefly, the PCR mastermix of 37.5 ul of nuclease free water, 5 ul 10x 
easy A buffer, 4ul of 2.5 mM dNTP mix, 1ul each of 10 uM working concentration 
forward and reverse primer and 0.5 ul of Easy A enzyme were mixed with 1 ul of 100 
ng of DNA template then put in the thermocycler set condition at (i) 4 minutes at 
95°C then (ii) 35 cycles of 30 seconds at 95°C, 30 seconds at 60°C and 60 seconds 
at 72°C. The last step of final extension of (iii) 7 minutes at 72°C, the product was 
then put on hold at 4°C until use. The 3’ overhangs were added to the PCR product 
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on ice using 1 unit of TAQ (0.5uL). Heated 8-10 minutes at 72°C and returned to ice. 
Added 1 ul of salt solution and 1 ul of vector to 4 ul of PCR product and incubated 5 
minutes at room temperature then returned to ice. To transform the vector into 1-shot 
cells, 2 ul of cloning reaction were added and mixed gently, put on ice for 5 minutes, 
heat shocked in 42°C water bath and immediately put back to ice. The next step was 
to incubate the cells with 250 ul of SOC in 37°C shaking incubator for 1 hour then 
plated using x-gal as the indicator, let the cells grow for 24 hours at 37°C. Tested the 
fidelity of the cloning, the screening PCR were then performed. The mixtures of 15.1 
ul of nuclease free water, 2.0 ul of 10x buffer, 1.2 ul of 25 mM working concentration 
of magnesium, 0.8 ul of 2.5 mM of dNTP mix, 0.4 ul each of screening forward and 
reverse primer and 0.1 L of Taq polymerase were mixed with the coloniesthat were 
picked by the pipette tip and process to the themocycler the same condition as 
above.  
After the screening PCR was done, the plasmic cells of choice were going 
through the rapid isolation of plasmid DNA using Promega Wizard Plus system 
(Promega Corporation. Madison, WI). This system can be used to isolate plasmid 
from E. coli hosts, which we were using as one-shot cell suitable for the plasmid is 
less than 20,000 bp in size. The principle of this method is to lyse bacteria cell to 
separate out the plasmid using column and a series of wash solutions. 
The plasmid was then sent to Applied Genomics Technology Center (Detroit, 
MI) for sequencing. The predicted products of gene from each bacterium were used 
to compare for matching genome using the BLAST algorithm 
(www.ncbi.nlm.nih.gov). After linearized the plasmid and serial dilutions were 
performed and keep in -20°C until needed.  
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RESULTS 
All primers were sensitive and specific for the strain they were designed to 
target when amplified with the diluted ATCC DNA. The sequence of the clone 
products were compared (http://blast.ncbi.nlm.nih.gov) and showed to be 96-100% 
similarity to the 16s r RNA sequence of Bifidobacterium spp. and Lactobacillus spp. 
as expected. 
Total bacteria in the test samples were qualified by Touchdown PCR. Gel 
electrophoresis of PCR product proved the presence of bacteria DNA in test 
samples. The concentrations and quality of the sample solutions were also analyzed 
by spectrophotometer. 
 
ZR fecal kit 
After collecting 0.15 g of fecal sample, extracted following the manufacturers 
procedure, the products were inspected using Nanodrop spectrophotometer (Thermo 
scientific Inc. Pittsburgh, PA). The result shows that DNA yield was not sufficient 
(lower than 250 ng/ul) and the 260/280 ratio were lower than 1.8. Then we repeated 
the experiment again using fresh fecal sample, which increased yield of DNA, 
storage sample in frozen form did not affect the quality of the sample. The 
experiment shows that 0.075 g was sufficient enough for DNA extraction. To improve 
texture and lysis ability, fecal material were soaked in nuclease free water for 10 
minutes, then hand homogenized and vertex using bench top vertex at 8,000 xg for 5 
minute. When finished the last step in protocol, transferred elute DNA to prepared 
IV-HRC spin filter one more time. The dilution of elution buffer has no effect to the 
extraction method.  
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During the quantization of extracted DNA by Nanodrop spectrophotometer, it 
was found that the 260/280 ratio failed to reach the acceptable range. Even though 
the reason might come from the preservatives that are used in the column and might 
not affect the usability of the product, but to ensure the quality, the columns were 
washed with 400 ul of nuclease free water to get rid of access reagent. The result 
showed that 260/280 ratio value had improved. (Figure 2) 
Since some of the PCR gel results showed multiple bands, the possibility 
might be RNA contamination. The company claimed that this kit was designed for 
complete RNA hydrolysis. But to ensure the results, we extended time period when 
feces mixed with DNA binding buffer. Results still showed multiple bands and smear 
in PCR gel. So later on, RNase treatment was done on DNA extraction solution 
before running PCR with Beta-actin primer. The results showed that the additional 
band disappeared in some experiments, but some were still present. 
The 20,25,30 and 35 cycles of PCR amplified with Beta-actin primer were 
performed in combination with the different dilution of extracted DNA and the results 
of PCR gel showed that there are linear relationship between the concentration of 
DNA presented in the samples and the intensity of the band when exposed to UV 
light. 
Attempting to find the right annealing temperature, gradient PCR was 
performed on 55.1, 56.1, 56.8, 58.2, 58.9, and 60.0 °C using BiBre primer. The 
template was amplified twice. First, used ATCC DNA amplified with Bifid1 primer. 
Then inserted into plasmid, grew and amplified again using species specific primer. 
Results show that all of the annealing temperatures were suitable to amplify these 
bacteria DNA. (Figure.3) 
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 Touchdown PCR was later used in the experiments but the DNA extraction 
using ZR fecal kit still failed to show the acceptable amplification signal. 
 
 
DNAzol Direct 
 Since ZR Fecal kit failed to provide the DNA which can be amplified by PCR, 
DNAzol was chosen. First, the experiment was focused on the appropriate amount of 
feces used since too much sample can decrease the efficiency of the DNAzol 
solution. Experiments were attempted to find the appropriate among in range of 1-10 
mg of fresh frozen mouse feces. The best yield came from using the pipette tip to 
touch the sample (same method when performing plasmid recombinant screening 
PCR), and mixed with 0.1 ml Nuclease-free water than added DNAzol direct solution. 
Next, we continue on the trial of various incubation temperatures, incubation time 
and the method of mixing (Table.3), results in the best condition which showed; for 
incubation  temperature, between 85°C- 90°C and 95°C, 95°C yield the best results 
and 15 minutes of incubation time is better than 10 minutes.  For mixing method, 
several techniques of hand homogenized and different length of vertex time were 
used. The results showed that the more the sample broke down, the better extraction 
of DNA. So we decided to use 30 seconds on bench top vertex. Centrifuge at 32000 
rpm for 1 minute after the extraction process helped improve the quality also. 
 After performing touchdown PCR using the template DNA extracted via this 
method, amplified with both genus specific and species specific primers; results 
shown in Table 3. At first, the PCR gel results showed band in negative control which 
were thought of as contamination during PCR mixture preparation. But later on we 
25 
 
 
 
found out that the reason was from miscalculation of primer concentration resulted in 
primer dimerization. 
To ensure that there is no PCR inhibitor present in the fecal material, 
experiment was formulated by mixing the fecal material with Bifidobacterium breve 
15701from www.ATCC.org, which grew into live cell culture. PCR gel results show 
the DNA amplification of BiBre and Bifid1 primer on mixture of feces with live cell 
culture and dry cell, but failed to show signal on fresh feces, fresh frozen feces and 
feces that were collected directly from young mice colon incision. (Figure 4-a, b) 
The experiment was repeated again using Lacto and Bifid2 primer. Results 
showed that, with touchdown PCR, both primers could detect the presence of 
Lactobacillus spp. and Bifidobacterium spp. in fecal material that was collected 
directly from mice colon incision. Bifid2 primer could also detected bacteria sample 
that was collected by scraping mucosa of mouse colon, but not present in Lacto 
primer PCR result. Both primers could not amplify DNA of the whole colon without 
incision. (Figure 5-a, b) 
Touchdown PCR was performed at 45 cycles on serial dilution of 
Bifidobacterium breve colony to check the sensitivity of Bifid1 primer and BiBre 
primer. The results show that G.Bibif1 primer could detect the presence of 
Bifidobacterium breve as low as the dilution of 10-5 and for BiBre primer, it was the 
dilution of 10-6. (Figure 6-a, b) 
The sensitivity of Bifid2 primer was also checked by detecting the serial 
dilution of Bifidobacterium breve cell culture DNA, the result shows that it could 
detect the DNA presence as low as dilution of 10-8. (Figure 6-c) 
The experiment continues further to see the lowest concentration of diluted 
fecal DNA sample that Bifid1 and BiBre primer could detect. The gel electrophoresis 
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results show that there are multiple bands present in both fresh and fresh frozen 
fecal samples. In BiBre primer can detect as low as 1:100 times dilution in both fresh 
and fresh frozen fecal samples. This is the unknown DNA concentration since the 
sample started off with pipette tip touching method, and the extracted DNA in 
DNAzol solution could be used in PCR mixture without unnecessary PCR purification 
step. In case of G.Bibif1 primer, results show multiple bands and could detect as low 
as 1:50 times dilution in fresh fecal sample but detected none in fresh frozen fecal 
sample. (Figure 7-a, b, c) 
DNA extraction from fecal matter was used to test Lacto primer sensitivity. 
The results show, at the primer concentration of 0.1 uM, the last concentration 
detection was at 394 ag. (Figure 8) 
The serial dilution of DNA extracted from fresh frozen feces was amplified 
with Lacto primer. The results show that primer could detect as low as 1:100 times 
dilution (started off with pipette tip touching method as DNAzol Direct protocol). 
(Figure 9) 
 
TA Sub-Cloning and Sequencing 
 The primer accuracy were checked by compared both genus specific (Bifid1 
primer) and species specific primers (BIA, BiBre, BiLon primer). PCR amplified 
results to known bacteria species ordered from www.ATCC.org ; Bifidobacterium 
adolescentis catalog number 15703D, Bifidobacterium breve catalog number 
15700D-5 and Bifidobacterium infantis catalog number 15697D. 
In genus specific primer shows 99% match with B. longum sub species 
infantis, B. breve and B. adolescentis. In case of species specific primer, the results 
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show that its 96% similar to B. longum sub species infantis and 100% similar to B. 
breve and B. adolescentis as expected. 
The first sample using fresh feces collected from young mice, extracted DNA 
using ZR Fecal kit. Then the DNA was amplified by touchdown PCR, using Bifid1 
primer. The product was cloned and sent for sequencing. The resulting sequence 
was compared against 16S rRNA of each species, and the sample sequence 
showed to be 96% matched to Bifidobacterium thermacidophilum subsp. 
Thermacidophilum.  
 While developing the DNAzol direct extraction method, the PCR product 
collected from young mice feces amplified with Bifid1 were sent to sequencing but 
the results show no signal. The size of this DNA fragment was 250-550 base pair.  
 In case of DNAzol Direct DNA extracting method, fresh frozen fecal sample 
was amplified with Lacto primer. Sequencing results show 99% match with 
Lactobacillus reuteri 16S ribosomal RNA gene.  
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Primers test 
Sample sequencing results compared to a query sequence from database of 
bacteria using BLAST program. (http://blast.ncbi.nlm.nih.gov) 
 
 Bifid1 genus specific primer amplified on ATCC Bifidobacterium breve catalog 
number 15700D-5, results in 99% match Bifidobacterium breve strain 885 16S 
ribosomal RNA gene.  
Query  1    ATGGCGGGGTAACGGCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41   ATGGCGGGGTAACGGCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGC  100 
 
Query  61   CACATTGGGACTGAGATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  101  CACATTGGGACTGAGATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCA  160 
 
Query  121  CAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGGAGGCCTTCGGGTTGTAA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  161  CAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGGAGGCCTTCGGGTTGTAA  220 
 
Query  181  ACCTCTTTTGTTAGGGAGCAAGGCACTTTGTGTTGAGTGTACCTTTCGAATAAGCACCGG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  221  ACCTCTTTTGTTAGGGAGCAAGGCACTTTGTGTTGAGTGTACCTTTCGAATAAGCACCGG  280 
 
Query  241  CTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCAAGCGTTATCCGGAATTATTG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  281  CTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCAAGCGTTATCCGGAATTATTG  340 
 
Query  301  GGCGTAAAGGGCTCGTAGGCGGTTCGTCGCGTCCGGTGTGAAAGTCCATCGCTTAACGGT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  341  GGCGTAAAGGGCTCGTAGGCGGTTCGTCGCGTCCGGTGTGAAAGTCCATCGCTTAACGGT  400 
 
Query  361  GGATCCGCGCCGGGTACGGGCGGGCTTGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGT  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  401  GGATCCGCGCCGGGTACGGGCGGGCTTGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGT  460 
 
Query  421  AACGGTGGAATGTGTAGATATCGGGAAGAACACCAAGGGCGAA  463 
            |||||||||||||||||||||||||||||||||||| |||||| 
Sbjct  461  AACGGTGGAATGTGTAGATATCGGGAAGAACACCAATGGCGAA  503 
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 BiLon species specific primer amplified on ATCC Bifidobacterium infantis 
catalog number 15697D, results in 96% match with Bifidobacterium longum gene for 
16S rRNA strain: JCM 7011.  
 
Query  4    CGCTTGCTCCCCGATAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACGCGGCGTC  63 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  385  CGCTTGCTCCCCGATAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACGCGGCGTC  326 
 
Query  64   GCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCT  123 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  325  GCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCT  266 
 
Query  124  GGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCGTCGAAGC  183 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  265  GGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCGTCGAAGC  206 
 
Query  184  CACGGTGGGCCGTTACCCCGCCGTCAAGCTGATAGGACGCGACCCCATCCCATACCGCGA  243 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  205  CACGGTGGGCCGTTACCCCGCCGTCAAGCTGATAGGACGCGACCCCATCCCATACCGCGA  146 
 
Query  244  AAGCTTTCCCAGAAGACCATGCGATCAACTGGAA  277 
            |||||||||||||||||||||||||||||||||| 
Sbjct  145  AAGCTTTCCCAGAAGACCATGCGATCAACTGGAA  112 
 
 
 
 BiBre species specific primer amplified on ATCC Bifidobacterium breve 
catalog number 15700D-5 results in 100% match with Bifidobacterium breve gene 
for 16S rRNA strain: JCM 1192.  
 
 
Query  1    ACAAAGTGCCTTGCTCCCTAACAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  404  ACAAAGTGCCTTGCTCCCTAACAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACG  345 
 
Query  61   CGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  344  CGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTA  285 
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Query  121  GGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  284  GGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCG  225 
 
Query  181  TCGAAGCCATGGTGGGCCGTTACCCCGCCATCAAGCTGATAGGACGCGACCCCATCCCAT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  224  TCGAAGCCATGGTGGGCCGTTACCCCGCCATCAAGCTGATAGGACGCGACCCCATCCCAT  165 
 
Query  241  GCCGCAAAGGCTTTCCCAACACACCATGCGGTGTGATGGAGCATCCGG  288 
            |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  164  GCCGCAAAGGCTTTCCCAACACACCATGCGGTGTGATGGAGCATCCGG  117 
 
 
 
 BIA species specific primer amplified on ATCC Bifidobacterium adolescentis 
catalog number 15703D results in 100% match with Bifidobacterium adolescentis 
strain ATCC 15703 16S ribosomal RNA gene.  
 
 
Query  1    GGAAAGATTCTATCGGTATGGGATGGGGTCGCGTCCTATCAGCTTGATGGCGGGGTAACG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  208  GGAAAGATTCTATCGGTATGGGATGGGGTCGCGTCCTATCAGCTTGATGGCGGGGTAACG  267 
 
Query  61   GCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  268  GCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGA  327 
 
Query  121  GATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  328  GATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGC  387 
 
Query  181  CTGATGCAGCGACGCCGCGTGCGGGATGACGGCCTTCGGGTTGTAAACCGCTTTTGACTG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  388  CTGATGCAGCGACGCCGCGTGCGGGATGACGGCCTTCGGGTTGTAAACCGCTTTTGACTG  447 
 
Query  241  GGAG  244 
            |||| 
Sbjct  448  GGAG  451 
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Fecal samples test 
 Bifid1 genus specific primer amplified on fecal sample results in 96% match 
with Bifidobacterium thermacidophilum subsp. thermacidophilum gene for 16S rRNA, 
strain: NBRC 106100.  
 
Query  1    CTCCTGGAAACGGGTGGTAATGCCGGATGTTCCCGCGCCCCGCATGGGGTGCGGGGAGAG  60 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  124  CTCCTGGAAACGGGTGGTAATGCCGGATGTTCCCGCGCCCCGCATGGGGTGCGGGGAAAG  183 
 
Query  61   CTTTTGCGGCGTGGGATGGGGTCGCGTCCTATCAGCTTGTTGGCGGGGTGAGGGCCCACC  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  184  CTTTTGCGGCGTGGGATGGGGTCGCGTCCTATCAGCTTGTTGGCGGGGTGAGGGCCCACC  243 
 
Query  121  AAGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGAGATACGG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  244  AAGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGAGATACGG  303 
 
Query  181  CCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  304  CCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC  363 
 
Query  241  AGCGACGCCGCGTGCGGGATGGGGGCCTTCGGGTTGTAAACCGCTTTTGTTTGGGAGCAA  300 
            |||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct  364  AGCGACGCCGCGTGCGGGATGGAGGCCTTCGGGTTGTAAACCGCTTTTGTTTGGGAGCAA  423 
 
Query  301  GCCCTTCGGGGTGAGTGTACCTTTCGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGC  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  424  GCCCTTCGGGGTGAGTGTACCTTTCGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGC  483 
 
Query  361  GGTAATACGTAGGGTGCGAGCGTTATCCGGATTTATTGGGCGTAAAGGGCTCGTAGGCGG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  484  GGTAATACGTAGGGTGCGAGCGTTATCCGGATTTATTGGGCGTAAAGGGCTCGTAGGCGG  543 
 
Query  421  TTCGTCGCGTCCGGTGTGAAAGTCCATCGCCTCACGGTGGATCTGCGCCGGGTACGGGCG  480 
            |||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||| 
Sbjct  544  TTCGTCGCGTCCGGTGTGAAAGTCCATCGCCTAACGGTGGATCTGCGCCGGGTACGGGCG  603 
 
Query  481  GGCTGGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGTAACGGTGGAATGTGTAGATATC  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  604  GGCTGGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGTAACGGTGGAATGTGTAGATATC  663 
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Query  541  GGGAAGAACACCAAGGGCGAA  561 
            |||||||||||||| |||||| 
Sbjct  664  GGGAAGAACACCAATGGCGAA  684 
 
 
 
 Lacto genus specific primer amplified on fecal sample results in 99% match 
with Lactobacillus reuteri strain MF2-2 16S ribosomal RNA gene.  
 
Query  300  CACCGCTACACATGGAGTTCCACTCTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATG  359 
            |||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||| 
Sbjct  676  CACCGCTACACATGGAGTTCCACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATG  617 
 
Query  360  CACTTCTTCGGTTAAGCCGAAGGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCT  419 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  616  CACTTCTTCGGTTAAGCCGAAGGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCT  557 
 
Query  420  TTACGCCCAATAAATCCGGATAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACG  479 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  556  TTACGCCCAATAAATCCGGATAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACG  497 
 
Query  480  TAGTTAGCCGTGACCTCCTGGTTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCAC  539 
            |||||||||||||| | ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  496  TAGTTAGCCGTGACTTTCTGGTTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCAC  437 
 
Query  540  GTTCTTCTCCAACAACAGAGCTTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGC  599 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  436  GTTCTTCTCCAACAACAGAGCTTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGC  377 
 
Query  600  TCCATCAGGCTTGCGCCCATTGTGGAAGATTCCCTACTGCT  640 
            ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  376  TCCATCAGGCTTGCGCCCATTGTGGAAGATTCCCTACTGCT  336 
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Figure 3 Electrophoresis gel of Gradient PCR in different annealing temperature, 
using BiBre primer amplified ATCC DNA of B. breve, B.adolescentis and B. infantis 
at 55.1, 56.1, 56.8, 58.2, 58.9 and 60.0 °C. 
 The figure shows that BiBre primer can be used at the annealing temperature 
ranging from 55.1-60.0°C to detect the presence of B. breve, B.adolescentis and B. 
infantis. 
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Figure 4-a Electrophoresis gel of Touch-down PCR amplification products, using 
BiBre primer, from live cell culture, dry cell culture and feces. 
Samples used - Lane1,2) 1:2 dilution of ATCC B. breve DNA; Lane3,4)ATCC B. 
breve dry cell culture; Lane5,6) ATCC B. breve live cell culture; Lane7,8) fresh 
collected feces; Lane9,10) frozen fresh collected feces; Lane11,12) feces collected 
directly from colon incision; Lane13,14) fresh collected feces combined with dry cell 
culture; Lane15,16) frozen fresh collected feces combined with dry cell culture; 
Lane17) fresh collected feces combined with live cell culture; Lane18) frozen fresh 
collected feces combined with live cell culture. 
 From this figure, the results show that BiBre primer could detect the presence 
of B.breve in the form of DNA extraction, live and dry cell cultures with or without the 
presence of fecal material. This proves that there is no PCR inhibitor present in 
feces.  This extracting method didn’t yield the results that are usable for PCR when 
performed on fecal samples alone. 
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Figure 4-b Electrophoresis gel of Touch-down PCR amplification products, using 
Bifid1 primer, from live cell culture, dry cell culture and feces. 
Samples used - Lane1) 1:2 dilution of ATCC B. breve DNA; Lane2) ATCC B. breve 
dry cell culture; Lane3) ATCC B. breve live cell culture; Lane4) fresh collected feces; 
Lane5) frozen fresh collected feces; Lane6) feces collected directly from colon 
incision; Lane7) fresh collected feces combined with dry cell culture; Lane8) fresh 
collected feces combined with live cell culture. 
 In the case of Bifid1 primer, the results also showed that it could be detected 
in the presence of B. breve in the form of DNA extraction, live and dry cell culture 
with or without the presence of fecal material. It didn’t yield the results that are 
usable for PCR when performed on fecal samples alone. 
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Figure 5-a Electrophoresis gel of Touch-down PCR amplification products, using 
Bifid2 primer, from mouse colon mucosa scraping, mouse whole colon and feces. 
Samples used – Lane1) fresh collected feces; Lane2) frozen fresh collected feces; 
Lane3) feces collected directly from colon incision; Lane4) mouse colon mucosa 
scraping; Lane5) mouse whole colon. 
 In the case of Bifid2 primer, the results showed that it could detect some 
Bifidobacterium in mouse colon feces and mouse colon mucosa but couldn’t detect 
fecal material in both freshly collected and pre-frozen feces, the whole colon also did 
not yield the results. 
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Figure 5-b Electrophoresis gel of Touch-down PCR amplification products, using 
Lacto primer, from mouse colon mucosa scraping, mouse whole colon and feces. 
Samples used – Lane1) fresh collected feces; Lane2) frozen fresh collected feces; 
Lane3) feces collected directly from colon incision; Lane4) mouse colon mucosa 
scraping; Lane5) mouse whole colon. 
 Lacto primer could detect the presence of Lactobacillus spp. DNA in the PCR 
product of freshly collected feces DNA, the pre-frozen feces and the feces that 
collected directlyfrom colon incision. The PCR results failed to show signal in the 
case of the sample of mouse mucosa and whole mouse colon. 
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Figure 6-a Electrophoresis gel of Touch-down PCR amplification products, testing 
on Bifid1 primer sensitivity test, using B. Breve live colony as a template. 
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4) 
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution. 
 
  
 
 
Figure 6-b Electrophoresis gel of Touch-down PCR amplification products, testing 
on BiBre primer sensitivity test, using B. Breve live colony as a template. 
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4) 
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution. 
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Figure 6-c Electrophoresis gel of Touch-down PCR amplification products, testing 
on Bifid2 primer sensitivity test, using B. Breve live cell colony as a template. 
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4) 
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution; Lane8) 
10-7 dilution; Lane9) 10-8 dilution. 
 Bifid1 primer and BiBre primer sensitivity test on B. Breve live cell colony 
showed that the primer could detect the presence of bacteria DNA as low as the 
dilution of 10-6, while Bifid2 primer was at 10-8.  The concentration was unknown 
since the sample was collected by touching the pipette tip directly to the colony. 
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Figure 7-a Electrophoresis gel of Touch-down PCR amplification products, using 
BiBre primer, from fresh collected feces DNA extraction by DNAzol direct solution. 
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of DNA 
extraction; Lane3) 1:20 dilution of DNA extraction; Lane4) 1:50 dilution of DNA 
extraction; Lane5) 1:100 dilution of DNA extraction. 
 
 
 
 
Figure 7-b Electrophoresis gel of Touch-down PCR amplification products, using 
BiBre primer, from frozen fresh collected feces DNA extraction by DNAzol direct 
solution. 
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of DNA 
extraction; Lane3) 1:20 dilution of DNA extraction; Lane4) 1:50 dilution of DNA 
extraction; Lane5) 1:100 dilution of DNA extraction. 
 
41 
 
 
 
 
 
Figure 7-c Electrophoresis gel of Touch-down PCR amplification products, using 
Bifid1 primer, from fresh collected and frozen fresh collected feces DNA extraction 
by DNAzol direct solution. 
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of fresh 
collected feces DNA extraction; Lane3) 1:50 dilution of fresh collected feces DNA 
extraction; Lane4) 1:10 dilution of frozen feces DNA extraction; Lane5) 1:50 dilution 
of frozen feces DNA extraction. 
 When attempt to amplify the DNA extraction using Bifid1 primer and BiBre 
primer, the PCR  results  showed  multiple  bands  and a decrease in  the  
concentration.  The template couldn’t solve the problem. 
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Figure 8 Electrophoresis gel of Touch-down PCR amplification products, testing on 
Lacto primer sensitivity test, using DNA extracted from feces in different 
concentration as a template. 
Samples used – Lane1) 15.76 ng/ul; Lane2) 7.88 ng/ul; Lane3) 3.94 ng/ul.; Lane4) 
3.94×10-1 ng/ul.; Lane5) 3.94×10-2 ng/ul.; Lane6) 3.94×10-3 ng/ul.; Lane7) 3.94×10-4 
ng/ul.; Lane8) 3.94×10-5 ng/ul.; Lane9) 3.94×10-6 ng/ul.; Lane10) 3.94×10-7 ng/ul. 
 
 
 
 
Figure 9 Electrophoresis gel of Touch-down PCR amplification products, using on 
Lacto primer ,on DNA extracted from frozen fresh collected feces using DNAzol 
direct solution. 
Samples used – Lane1) 1:10 dilution; Lane2) 1:2 dilution; Lane3) 1:5 dilution; Lane4) 
1:7 dilution; Lane5) 1:100 dilution of frozen feces DNA extraction. 
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 Lacto primer could detect the presence of DNA extracted via this method 
even at the low concentration of DNA present. In primer sensitivity test (fig.8), the 
lowest concentration detected was at 3.94×10-7 ng/ul. 
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CONCLUSION 
ZR Fecal kit 
1. Fresh collected feces worked better than dry. Fecal sample could be frozen 
and stored at -20°C without decline in DNA quality. 
2. To improve the bacteria-lysis ability, many texture improving techniques were 
used i.e.; hand homogenization, bench top vertex. The more the samples 
broke down, the better the results. 
3. PCR method was started off with different annealing temperatures (gradient 
PCR) and number of PCR cycles. Later on, TDPCR was chosen in order to 
cover more temperature ranges and reduced the amplification of nonspecific 
sequences. For PCR reaction solution, Go Tag Green with DMSO gave the 
best amplifying results.  
4. PCR results from Beta-actin primer and Bifid1 primer showed inconsistent 
results, either 2 bands or smear. The dilution of template and RNase 
treatment were tried but could not improve the outcome. 
5. ZR Fecal Kit, after adjusting the protocol, could not extract bacteria DNA at 
acceptable spectrophotometer’s 260/280 wave length ratio. The concentration 
of bacteria DNA was low, and could not show acceptable results on 
electrophoresis gel after PCR. 
6. However, with the correct G.bidif1 primer concentration, mouse fecal DNA 
could be amplified by PCR. The sequence matched 96% to Bifidobacterium 
themacidophilum. For species specific primer, they fail to give acceptable 
PCR results. 
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DNAzol Direct 
1. The most suitable among mouse fecal samples, either fresh or frozen, was 
obtained by touching the pipette tip to the sample (same method as screening 
PCR in plasmid cloning procedure). But this DNA extraction method needed 
to extract daily since the DNAzol Direct solution is not suitable to store DNA 
sample. 
2. The most efficient incubation condition was 95°C for 15 minutes on heating 
block, then vertex for 30 seconds followed by centrifuge at 32000 rpm for 1 
minute. 
3. DNAzol Direct DNA extract method was preferred. Yield from template DNA 
could be amplified in PCR and showed results in electrophoresis gel and it 
required fewer steps in protocol. 
4. There was no PCR inhibitor in feces. Experiments by mixing ATCC culture 
into fecal sample and results in amplification signal on PCR gel. 
5. Fecal DNA extraction by this method, when amplified with  Lacto genus 
specific primer, yielded 99% match with sequence of Lactobacillus reuteri in 
database. 
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The reaction sensitivity test 
The sensitivity of reactions was evaluated by serial dilution of ATCC DNA: 
B. adolescentis, B. breve, and B. infantis. 
1. Bifid1 genus specific primer, with template from all 3 species, could detect 
DNA up to a dilution of 10-10, which contained approximately 10 ag of DNA. 
2. For species specific primers,  
-BIA primer could detect DNA up to a dilution of 10-8, or 1 fg of DNA. 
-Both BiLon and BiBre primer could detect DNA up to a dilution of 10-7, 
or 10 fg of DNA. 
 
The serial dilution of ATCC Bifidobacterium breve culture was also used as a 
template to evaluate the sensitivity of the reaction. 
1. Bifid1 genus specific primers could detect DNA up to the dilution of 10-5 or 
approximate amount of 1 pg of DNA, while Bifid2 was 10-8 or approximate 
amount of 1 fg of DNA. 
2. BiBre species specific primer could detect DNA up to the dilution of 10-6, or 
approximate amount of 100 fg of DNA. 
 
The PCR product of  Bifid1 primer amplified against ATCC bacteria DNA:-
resulted in 99% match with all 3 bacteria sequences (B. breve, B. Adolescentis, and 
B. Longum). When using BiBre and BIA primers amplified against B. breve and B. 
infantis ATCC DNA, the sequences were 100% similar to each species in bacteria 
database. For BiLon primer, the results yield 96% match. 
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DISCUSSION 
During the sample collection, we used both young and old mice. The disparity 
in age of the mice might play an important role in the occurrence of bacteria detected 
in fecal samples, due to unequally late development of the young mice’s intestinal 
ecosystems (67). 
 The presence of bacteria in the feces might not represent the type or quantity 
of bacteria that inhabitant the colon. From the experiments, some types can be 
detected more in colons but not in feces. The reason might be attributable to the 
surface protein called adhesion in the bacteria cell wall, which aids the binding of 
that bacterium to the receptor molecule on the surface of a susceptible host cell. This 
type of contact enables the bacteria to adhere, colonize, and resist physical removal 
like flushing.  
 For example, Bifidobacterium bifidum has been shown to have the highest 
adhesion to the intestinal epithelial cell (IEC), using the specific lipoprotein called 
Bifidobacterial outer protein A (bopA) that helps enhanced adhesion to IEC (68). 
 Factors that determine or help promote the colonization of each different 
bacterium include the mobility which helps increase the chance of connection to host 
and spreading of the colonies, in addition to how well the bacteria can adhere and 
resist physical removal. Some bacteria can invade the host cell and fight for nutrients 
with other species. If the bacteria can defence against the host’s innate immune 
defuses system, such as phagocytosis, and adapt to the immune defences, then it 
can increase the chance to colonize. 
Many factors could come into play in the regulation of the studied microflora, 
including local immune mechanism, the substrates supplied by the mucosa, 
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interactions between different microbial species, initial digestion transit time, pH, and 
the local supply of oxygen (58). 
Primer design 
16S ribosomal RNA is the species-specific signature sequences of prokaryotic 
ribosome used for identifying the bacteria. It consists of 30 small subunits, 
approximately 1.5 kb in length. This region acts as a framework and defines the 
placement of ribosomal protein. 3’ end of 16S rRNA binds upstream to AUG start 
codon on mRNA initiate protein synthesis. It is also interact with 23S rRNA helping 2 
ribosomal subunits to bind. This helps  to stabilize the right codon-anticodon pairing 
in A site (ribosomal-decoding site). 16S rRNA is essential and present at least one 
copy in the genome (79). 
The primer design targeted the 16S ribosomal RNA, because it is the 
conservative regions content, involves the bacteria species essential functions, is 
used for generating amplicons, and benefits greatly from the phylogenetic and 
taxonomic studies. In PCR technical, the V1-V9 regions of 16S rRNA genes are 
usually the target for primer design (67). The over-relaxed match of primer design 
can cause PCR failure. 
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ZR Fecal Kit 
While performing the DNA extraction using the ZR Fecal kit, as show in the 
sample number 21,22,23 in table 2, the appearance of fecal lysed solution was 
different between each sample regardless of whether they were collected from the 
same subject or not. This could be due to the characteristic difference between each 
fecal sample i.e. fiber content, moisture content, food particle etc. 
  The sample quantitative DNA reading via Nano Drop spectrophotometer 
showed a value of 260/280 less than expected, possibly due to acidity in the 
solution. A simple change in the ionic strength would results in low 260/280 ratio 
(70). Another reason for this observation could be a slight shift in wavelength 
accuracy of the spectrophotometer, particularly the absorbance curve at 280 nm. For 
example, a 1 nm shift could affect as much as a 0.4 difference in the 260/280 ratio. 
(www.nanodrop.com). Lastly, the presence of nucleotides in the sample could affect 
the overall value of 260/280 ratio. When measuring each nucleotide individually, the 
values are as follows. Guanine equals 1.15, Adenine equals 4.50, Cytosine equals 
1.51, Uracil equals 4.00, and Thymine equals 1.47 (71). The ratio would depend on 
the composition of the nucleic acid that contaminated the sample. 
  After extraction, samples were processed with the PCR. The results of 
electrophoresis gel, extracted DNA using ZR Fecal kit showed multiple bands that 
could be the contamination of RNA. The ZR Fecal kit claims that the reagent in the 
kit help gets rid of all the RNA. To ensure this, the samples were treated with RNase 
to prevent secondary priming. But that still did not solve the problem. The reasons 
might due to contamination in negative controls or the accumulation of primer. Some 
samples showed smear in the gel that could be non-specific binding of primer to 
template DNA. 
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Non-specific binding causes by “hair pins” or the DNA-DNA binding. The 
results of this secondary structure DNA folding and knotting can decrease the 
productivity yield. The trouble can be resolved by adding dimethyl sulfoxide (DMSO) 
or glycerol, which helps minimize the secondary structure DNA by preventing the 
DNA self-complementarity. 
Other causes of non-specific binding include repeating of the DNA template, 
undesirable binding of primer and template, and incomplete primer binding which left 
5’end unattached to the template. One way to solve these issues is to use 
touchdown PCR, which in this experiment did not always yield the best results. 
Another method that needs further experimentation includes using hot start 
polymerase enzyme. Nested PCR which could also helps lower the amplification on 
unexpected primer binding site. Moreover, non-specific binding of primers can be 
fixed by manipulation of annealing temperature and/or the magnesium ion 
concentration (72). 
Another solution can be obtained from finding the right polymerase enzyme. 
For example, one can replace Taq polymerase enzyme with high-fidelity DNA 
polymerase. Normally, Taq polymerase has no 3’-5’ exonuclease activity which is 
prone to error amplification of DNA product, while these enzymes have engineered 
3’-5’ exonuclease activity which provide error-proof reading during synthesis. 
The concentrations of each reaction mixture are very important. Too much or 
too little of each part can cause PCR failure. From this experiment, primers 
concentration was 10 times too high, which results in primer dimerization. Primer 
dimerization causes the annealing of 3’ end from one primer to another, and then 
primer extends to complete the synthesis of the DNA strand. In this experiment, the 
solution was to find the optimum concentration of primer. Other conditions that 
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should be studied further include the increasing of MgCl2 concentration, the 
increasing or decreasing of annealing temperature, and the use of different primers 
(the longer base pair trend to be more specific). 
In this study, the primers that were used were based on previous studies, 
which had been designed and could be readily purchased.  These primers could be 
improved to achieve a better result. For example, to decrease non-specific priming 
the primer sequence should have C-G content between 40 and 60%. The distribution 
of C-G should be divided equally throughout the primer strands, and C-G sequence 
should not position at 3’ end of the primer. 
There are other possibilities such as using too much deoxy nucleotides 
(dNTPs) which has the ability to bind to magnesium ion and can decrease the 
magnesium ion concentration in the solvent. 
Magnesium ion should be added as the thermostable DNA polymerase co-
factor. If the concentration is too low, this could impair the working ability of Taq 
polymerase. Using too much can cause double stranded DNA stabilization, 
preventing completion of the denaturing process of the DNA strands. In case of non-
specific binding, high magnesium concentration aids the binding of incorrect 
template and primer. 
 
DNAzol Direct 
One challenge that needs to be overcome in recovery of DNA is finding the 
lysis method that could penetrate peptidoglycan, the heavily cross-linked structure in 
gram-positive bacteria cell wall. While conducting the experiment, many conditions 
and methods were used in order to cause interference of the cell wall. Some 
research found that glycoside hydrolyses enzymatic lysis could improve DNA yield. 
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For example, fecal material can be resuspended in bactozol enzyme solution or by 
using muramidases enzyme such as lysozyme and mutanolysin that hydrolyze the b-
1, 4 glycoside linkages in GlcNAc and MurNAc of the glycan backbone (31). Another 
possibility for improving lysis DNA yield is to use Labiase from Streptomyces 
filvissimus, the enzyme that could lyse gram positive bacteria wall. This enzyme also 
contains lysozyme and β-N-acetyl-D-glucosaminidase (73).  
Furthermore, since we directly used the mixture of fecal material with DNAzol 
direct in PCR mixture, it could be that the presences of multiple substances in fecal 
material inhibit the polymerase enzyme in the PCR analysis (74).The amount of fecal 
material that is suitable for both the extraction process and the PCR reaction is still in 
question. 
DNAzol direct was chosen instead of ZR Fecal kit because of the ability to 
extract the usable DNA and to reduce the number of steps in the process. 
Qualification of Bifidobacterium was performed using touchdown PCR with specific 
primers. This method was used in this study to avoid the non-specific binding 
amplification by gradually declining the annealing temperature template and primer. 
The PCR gel results were not as expected, maybe due to the high concentration of 
primer that caused primer dimerization.  
The present study has several strengths and weaknesses. Some strengths 
include: adequate sample size, controlled environment and dietary composition, 
adequate length of experimental period, and validation of results through use of two 
qualitative techniques (PCR and spectrophotometer) to analyze the same set of 
samples.  One weakness is the lack of a method to verify the development of the 
pathophysiological changes that are claimed to be responsible for the variation in 
bacterial levels in the GI tracts of the mice. For example, it would have been helpful 
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to analyze the pH of the intestines of the studied mice, or to study the morphology of 
the intestinal wells. In addition, the selected measure of outcome (i.e. the 
Bifidobacterium DNA in the fecal material) might not truly represent all that occurs in 
the flora of the GI tract. The amount of DNA extraction from each fecal sample might 
solely indicate the amount of Bifidobacterium population in cecum of the animal 
rather than that of the entire GI tract. Finally, the environmental conditions in the 
distal bowel, such as depletion of preferred energy substrates, might not be suitable 
for the growth of microbiota. Therefore, the DNA results from collected fecal material 
might be affected by this limitation (75). 
   Aging might significantly influence gastrointestinal health, by inhibiting the 
growth of beneficial GI microflora.  Therefore, further understanding of the regulation 
of gut microbiota will offer a basis for future studies to improve GI health in humans. 
Bifidobacterium plays an important role in the body, affecting the reactivity of the 
immune system and helps the other physiological functions (76). The lower amount 
or absence of Bifidobacterium may cause serious health consequences in the GI 
tract of the host. For example, colon cancer development can be promoted by the 
absence of protective Bifidobacterium strains. To this regard, dietary modifications 
such as supplementation of probiotics or prebiotics have been suggested to benefit 
in the prevention of diseases such as colon cancer. Indeed, probiotics would provide 
and immediately increase Bifidobacterium and prebiotics that would induce the 
growth and maintain the health of microbiota population (77). Further research in 
animals and humans, especially randomized controlled trials, is warranted. 
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Table 1. PCR primers used in this study 
Primer  Oligonucleotide sequence 
Amplicon 
size  
Annealing 
temp 
(Bacteria 
species) 
 ( 5'→3') (bp)  (°C ) 
    
Lacto [63] F:CACCGCTACACATGGAG 341 58 
Lactobacillus spp. R:AGCAGTAGGGAATCTTCCA 
Bifid1 [64] F:CTCCTGGAAACGGGTGG 549-563 58 
Bifidobacterium 
spp. R:GGTGTTCTTCCCGATATCTACA 
Bifid 2 [65] F:TCGCGTC(C/T)GGTGTGAAAG 243 58 
Bifidobacterium 
spp. R:CCACATCCAGC(A/G)TCCAC 
BiBIF [64] F:CCACATGATCGCATGTGATTG 278 63 
B. bifidum R:CCGAAGGCTTGCTCCCAAA 
BiBRE [64] F:CCGGATGCTCCATCACAC 288 60 
B. breve R:ACAAAGTGCCTTGCTCCCT 
BiLON [64] F:TTCCAGTGATCGCATGGTC 277 62 
B. longum R:TCSCGCTTGCTCCCCGAT 
BIA [66] F:GGAAAGATTCTATCGGTATGG 244 55 
B. adolescentis R:CTCCCAGTCAAAGCGGTT 
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Table 2. The ZR Fecal Kit Extraction Method 
 
       
   
Texture improvement 
 
      
sample  weight (mg) condition Hand homoginized Bench Top Vertex
 
1 150 dry feces no  no 
 
2 150 dry feces no,but soaked lysis buffer for 10 min no 
 
3 150 dry feces no,but soaked lysis buffer for 30 min no 
 
4 75 dry feces yes,and soaked in lysis buffer for 30 min  5 min 
 
5 75  fresh feces yes 5 min 
 
6 150  fresh feces yes  5 min 
 
7 75 frozen fresh feces yes  5 min 
 
8 150 frozen fresh feces yes  5 min 
 
9 75 fresh feces yes  5 min 
 
10 75 fresh feces yes  5 min 
 
11 75 fresh feces yes  5 min 
 
12 75 fresh feces yes  5 min 
 
13 75 fresh feces yes  5 min 
 
14 75 fresh feces yes  5 min 
 
15 75 frozen fresh feces yes  5 min 
 
16 75 frozen fresh feces yes  5 min 
 
17 75 fresh feces yes  5 min 
 
18 75 fresh feces yes  5 min 
 
19 75 frozen fresh feces yes  5 min 
 
20 75 frozen fresh feces yes  5 min 
 
21 75 frozen fresh feces yes  5 min 
 
22 75 frozen fresh feces yes  5 min 
 
23 75 frozen fresh feces yes  5 min 
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Procedure adjustment 
    
Sample Cell Lysis Improvement DNA Binding Improvement 
 
1 as protocal 1200 ul binding solution as protocal 
 
2 as protocal 1200 ul binding solution as protocal 
 
3 as protocal 1200 ul binding solution as protocal 
 
4 as protocal 1200 ul binding solution as protocal 
 
5 as protocal 1200 ul binding solution as protocal 
 
6 as protocal 1200 ul binding solution as protocal 
 
7 as protocal 1200 ul binding solution as protocal 
 
8 as protocal 1200 ul binding solution as protocal 
 
9 as protocal 1200 ul binding solution as protocal 
 
10 as protocal 1200 ul binding solution as protocal 
 
11 Vertex with lysis buffer 5 min 1200 ul binding solution as protocal 
 
12 Vertex with lysis buffer 10 min 1200 ul binding solution as protocal 
 
13 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1575 ul  
14 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1800 ul  
15 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1800 ul  
16 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1800 ul  
17 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1800 ul  
18 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
increased DNA binding solution to 
1800 ul  
19 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
adding ,increased binding time to 5 min 
 
20 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
adding ,increased binding time to 5 min 
 
21 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
adding ,increased binding time to 5 min 
 
22 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
adding ,increased binding time to 5 min 
 
23 
Vertex with lysis buffer 10 min,increase lysis buffer to 
1000 ul 
adding ,increased binding time to 5 min 
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Procedure adjustment (continue) 
  
Sample DNA Elution improvement 
1 as protocol 
2 as protocol 
3 as protocol 
4 repeated the last step by put the elute in the IV-HRC spin filter twice 
5 repeated the last step by put the elute in the IV-HRC spin filter twice 
6 repeated the last step by put the elute in the IV-HRC spin filter twice 
7 repeated the last step by put the elute in the IV-HRC spin filter twice 
8 repeated the last step by put the elute in the IV-HRC spin filter twice 
9 adding,increased of 100 ul elution buffer to elude the DNA in final step 
10 adding, increased of 50 ul elution buffer to elude the DNA in final step 
11 adding, increased of 50 ul elution buffer to elude the DNA in final step 
12 adding, increased of 50 ul elution buffer to elude the DNA in final step 
13 adding, increased of 50 ul elution buffer to elude the DNA in final step 
14 adding, increased of 50 ul elution buffer to elude the DNA in final step 
15 adding,washed the 1x column with 400 ul with nuclease-free water 
16 adding,washed the column with elute buffer twice 
17 adding,washed the 1x column with 400 ul with nuclease-free water 
18 
adding,washed the 1x column with 400 ul with nuclease-free water 
twice 
19 adding,diluted elute solution 1:10 with TE buffer 
20 adding,diluted elute solution 1:10 with TE buffer 
21 adding,diluted elute solution 1:10 with TE buffer 
22 adding,diluted elute solution 1:10 with TE buffer 
23 adding,diluted elute solution 1:10 with TE buffer 
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 Results 
 
   
Sample           Concentration (ng/ul)    260/280 Ratio 
1 97.37 1.36 
2 92.28 1.45 
3 71.96 1.47 
4 74.27 1.52 
5 120.11 1.33 
6 104.18 1.48 
7 123.22 1.54 
8 115.94 1.53 
9 53.59 1.26 
10 175.00 1.58 
11 57.76 1.52 
12 58.74 1.41 
13 99.01 1.60 
14 68.77 1.47 
15 155.98 1.80* 
16 101.46 0.93 
17 44.74 1.58 
18 141.42 1.82* 
19 117.61 1.83* 
20 170.87 1.85* 
21 48.75 1.78 
22 68.1 1.77 
23 35.35 1.72 
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Figure 10.1  DNA Concentration detected by Nanodrop Spectrophotometer. 
 
 
 
 
 
 
 
 
 
Figure 10.2  DNA Quality detected by Nanodrop Spectrophotometer 
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Table 3. The DNAzol Direct Extraction Method  
 
 
Procedure adjustment  
 
 
Sample weight (mg) 
incubation 
temperature (C °)   
Vertex time 
(sec)  
1 5.7 85 briefly  
2 4.3 85 briefly  
3 4.1 85 briefly  
4 2.9 85 10  
5 1.8 85 10  
6 1.4 85 30  
7 5.9 85 30  
8 4.7 85 30  
9 2.1 85 30  
10 4.8 room temperature 30  
11 4.4 room temperature 30  
12 3.6 room temperature 30  
13 5.0 90 10  
14 5.4 90 30  
15 4.9 90 10  
16 5.0 90 30  
17 4.8 95 30  
18 2.6 95 30  
19 4.8 95 30  
20 4.6 95 30  
21 2.9 95 30  
22 3.1 95 30  
23 4.8 95 briefly  
24 10.0 95 briefly  
25 12.6 95 briefly  
26 
touch with 
pipette tip  95 briefly  
27 
touch with 
pipette tip  95 briefly  
29 
touch with 
pipette tip  95 briefly  
 
note: Sample 21-24 were centrifuged at 32000 rpm after vertex 
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PCR Results 
 Sample amplified with g-bifid primer amplified with BiBre primer 
1 no n/a 
2 no n/a 
3 no n/a 
4 no no 
5 no no 
6 no no 
7 no no 
8 show but wrong size no 
9 show but wrong size no 
10 no no 
11 show but wrong size no 
12 no no 
13 show but wrong size no 
14 show but wrong size no 
15 show multiple bands  no 
16 show multiple bands  no 
17 show multiple bands  no 
18 show multiple bands  smear 
19 no n/a 
20 show yes 
21 show multiple bands  smear 
22 show multiple bands  show multiple bands 
23 no no 
24 show multiple bands  no 
25 show multiple bands  n/a 
26 show but wrong size n/a 
27 show but wrong size n/a 
29 show but wrong size n/a 
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Table 4. Results of PCR for amplification of Lacto, Bifid1, Bifid2, and 
      BiBre primer  
Template DNA souce 
Primer 
Lacto Bifid1 Bifid2 BiBre 
Fresh collected feces + - - - 
Fresh frozen feces + - - - 
ATCC dry cell + Feces N/A + + + 
ATCC live cell + Feces N/A + + + 
Feces collected directly from colon incision + - + - 
mouse colon mucosa - - + - 
Whole colon - - - - 
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Lactic acid bacteria (LAB) and Bifidobacterium are the most common types of 
microbes used as probiotics. They are present in the human gastrointestinal tract 
and have a significant influence on our health and well-being. Microbiota plays an 
important role in host metabolism and provides a natural defense mechanism 
against invading pathogens. This experiment was focusing on establish a method to 
detect the gastrointestinal tract microbiota, either by fecal or colonic tissue DNA 
extraction.  
 The experiment comparing 2 types of DNA extraction; ZR Fecal kit and 
DNAzol direct. DNAzol direct was easy to use but was not suitable for long term 
DNA storage, hence the sample need to be extract fresh when needed. The 
extracted DNA, when amplified with Lacto genus specific primer show 99% match 
with sequence of Lactobacillus reuteri in database. For primer sensitivity test, Bifid1 
genus specific primer could detect DNA up to a dilution of 10-10, or approximately 10 
ag of DNA. For species specific primers, BIA could detect DNA up to a dilution of 10-
8, or 1 fg of DNA. Both BiLon and BiBre primer could detect DNA up to a dilution of 
10-7, or 10 fg of DNA. The PCR product of Bifid1 primer amplified against ATCC 
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bacteria DNA:-resulted in 99% match with all 3 bacteria sequences (B. breve, B. 
Adolescentis, and B. Longum). When using BiBre and BIA primers amplified against 
B. breve and B. infantis ATCC DNA, the sequences were 100% similar to each 
species in bacteria database. For BiLon primer, the results yield 96% match.  
 The difference in age of the mice could play an important role in the presence 
of bacteria detected in fecal samples, due to unequally delayed development of the 
young mice’s intestinal ecosystems. The presence of bacteria in feces might not 
represent the type or quantity of bacteria that inhabitant the colon. One challenge 
that needs to be overcome in recovery of DNA is finding the lyses method that could 
penetrate peptidoglycan, the heavily cross-linked structure in gram-positive bacteria 
cell wall. Also find the method to verify the development of the pathophysiological 
changes, that are claimed to be responsible for the variation in bacterial levels in the 
GI tracts of the mice, would make the results more accurate. Further large-scale 
research in animals and humans, especially randomized controlled trials, is 
warranted. 
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